Wearable Robotics
Develops advanced wearable robotic systems and exoskeletons for neuromotor rehabilitation and industrial assistance.
- CEO / Founder
- Lucia Lencioni
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- €5.0M
- Latest Round
- Series A
- Key Investors
- CDP Venture Capital, MITO Technology, LIFTT, SIMEST, RoboIT, Toscana Next
Technology & Products
Key Products
["ALEx RS - Bilateral upper-limb exoskeleton with 5 degrees of freedom (4 active, 1 passive) for post-stroke rehabilitation, CE certified Class IIa medical device","ALEx S (Track-hold) - Rehabilitation device for upper limb passive training with gravity support and motion tracking","Wearable Walker - Lower limb robotic prototype for walking assistance","Industrial Exoskeleton Series - Solutions for manual material handling and overhead work support"]
Technological Advantage
Utilizes a proprietary tendon-actuated transmission system that ensures low weight and high 'transparency' (minimal resistance to natural movement), backed by over 25 years of academic research in human-robot interaction.
Differentiation
Value Proposition
Improves clinical outcomes for neurological patients through high-fidelity robotic assistance and reduces musculoskeletal strain for industrial workers using lightweight, ergonomic exoskeleton technology.
How They Differentiate
Proprietary tendon-actuated transmission system providing high 'transparency' (minimal resistance to natural movement) and low weight compared to traditional rigid-link systems. Integration with Virtual Reality (VR) 'serious games' enhances patient engagement and neuroplasticity.
Market & Competition
Target Customers
Rehabilitation clinics, hospitals, stroke survivors, and industrial manufacturing/logistics companies.
Industry Verticals
["Healthcare / MedTech","Physical Rehabilitation","Industrial Manufacturing","Logistics & Warehousing"]
Competitors
Hocoma (ArmeoPower), Tyromotion (Diego), Ekso Bionics (EksoUE), Myomo (MyoPro)
Growth & Milestones
Growth Metrics
Deployed 50+ robotic units in clinical hospitals and rehabilitation centers across 20 countries; holds 8 proprietary industrial patents.
Major Milestones
["Founded in 2014 as a spin-off from the PERCRO Lab of Scuola Superiore Sant'Anna","Obtained CE Mark and ISO 13485 certification for ALEX RS and ALEX S in 2019","Definitively acquired a family of 8 industrial patents from Scuola Superiore Sant'Anna in 2022","Closed €5M Series A funding round in April 2024 to scale international operations"]
Notable Customers
Clinical hospitals and rehabilitation centers across 20 countries, with over 50 ALEX RS units deployed internationally